At a glance

ClinicalIndex Comparison Record

N/ACompleted· 44 enrolled

Drug / intervention

Weight Loss +1 morebehavioral

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00475982

NCT00475982N/ACompleted

Compare CT.gov

Effect of Weight Loss on Prostate Cancer Pathology

VA Office of Research and Development·interventional·Posted May 21, 2007·Updated Jan 31, 2019

In Brief

A clinical study evaluating Weight Loss and No Weight Loss Group for Obesity and Prostate Cancer. Completed, enrolled 44 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if weight loss prior to radical prostatectomy effects chemical substances in the blood stream and prostate tissue that may affect prostate cancer development and progression.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsObesity, Prostate Cancer

CountriesUnited States

Collaborators--

Timeline

N/ACompletedFinished

200720082009201020112012201320142015201620172018201920202021202220232024202520262027

First PostedMay 2007

Enrollment StartJan 2009

Primary CompletionMar 2016

TodayJul 2026

First PostedMay 21, 2007

Enrollment StartJan 1, 2009

Primary CompletionMar 1, 2016

TodayJul 2, 2026

Enrollment to primary: 7.2 yearsPosted 19.1 years ago

Interventions

Weight Lossbehavioral

Subjects undergo a weight loss intervention prior to radical prostatectomy. The intervention includes weekly visits with the dietician, DEXA scanning, blood draws, and anthropometrics.

No Weight Loss Groupother

These subjects do not undergo a weight loss intervention prior to radical prostatectomy. This group does undergo DEXA scanning, blood draws, and anthropometrics prior to radical prostatectomy.